These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3863819)
1. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. Pugliese G; Spokas EG; Marcinkiewicz E; Wong PY J Biol Chem; 1985 Nov; 260(27):14621-5. PubMed ID: 3863819 [TBL] [Abstract][Full Text] [Related]
2. 9 alpha, 11 beta-prostaglandin F2: a new prostanoid with selective biosynthesis and unique biological activity. Pugliese G; Marcinkiewicz E; Wong PY Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():50-4. PubMed ID: 2959104 [No Abstract] [Full Text] [Related]
3. Metabolism of prostaglandin D2 in isolated rat lung: the stereospecific formation of 9 alpha,11 beta-prostaglandin F2 from prostaglandin D2. Hayashi H; Ito S; Watanabe K; Negishi M; Shintani T; Hayaishi O Biochim Biophys Acta; 1987 Feb; 917(3):356-64. PubMed ID: 3467796 [TBL] [Abstract][Full Text] [Related]
4. Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Liston TE; Roberts LJ Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6030-4. PubMed ID: 3862115 [TBL] [Abstract][Full Text] [Related]
5. Potential role for prostaglandin F2 alpha, D2, E2 and thromboxane A2 in mediating the metabolic and hemodynamic actions of sympathetic nerves in perfused rat liver. Iwai M; Gardemann A; Püschel G; Jungermann K Eur J Biochem; 1988 Jul; 175(1):45-50. PubMed ID: 3165341 [TBL] [Abstract][Full Text] [Related]
6. PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery rings. Roberts LJ; Seibert K; Liston TE; Tantengco MV; Robertson RM Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():427-9. PubMed ID: 2959090 [No Abstract] [Full Text] [Related]
7. Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase. Watanabe K; Iguchi Y; Iguchi S; Arai Y; Hayaishi O; Roberts LJ Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1583-7. PubMed ID: 3456602 [TBL] [Abstract][Full Text] [Related]
8. Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans. Wendelborn DF; Seibert K; Roberts LJ Proc Natl Acad Sci U S A; 1988 Jan; 85(2):304-8. PubMed ID: 3422430 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. Altin JG; Bygrave FL Biochem J; 1988 Feb; 249(3):677-85. PubMed ID: 3128268 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of prostaglandins D2 and F2 alpha in primary cultures of rat hepatocytes. Sago T; Nakayama R; Okumura T; Saito K Biochim Biophys Acta; 1986 Dec; 879(3):330-8. PubMed ID: 3465372 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin D2 is metabolized in humans to 9 alpha,11 beta-prostaglandin F2, a novel biologically active prostaglandin. Liston TE; Oates JA; Roberts LJ Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():365-7. PubMed ID: 2936123 [No Abstract] [Full Text] [Related]
13. Studies on the characterisation of prostanoid receptors: a proposed classification. Kennedy I; Coleman RA; Humphrey PP; Levy GP; Lumley P Prostaglandins; 1982 Nov; 24(5):667-89. PubMed ID: 6131499 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma. Orchard MA; Waddell KA; Lewis PJ; Blair IA Thromb Res; 1985 Sep; 39(6):701-10. PubMed ID: 3936223 [TBL] [Abstract][Full Text] [Related]
15. The effect of prostaglandin D2 on the blood vessels of the perfused isolated cotyledon of the human placenta. Abramovich DR; Page KR; Parkin AM Br J Pharmacol; 1984 Jan; 81(1):19-21. PubMed ID: 6584189 [TBL] [Abstract][Full Text] [Related]
16. Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. Liston TE; Roberts LJ J Biol Chem; 1985 Oct; 260(24):13172-80. PubMed ID: 3863815 [TBL] [Abstract][Full Text] [Related]
17. Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man. Hardy CC; Holgate ST; Robinson C Br J Pharmacol; 1986 Mar; 87(3):563-8. PubMed ID: 3467804 [TBL] [Abstract][Full Text] [Related]
18. Presence of prostaglandin D2, E2 and F2 alpha in rat pancreatic islets. Horie H; Narumiya S; Matsuyama T; Nonaka K; Tarui S Prostaglandins Leukot Med; 1984 Oct; 16(1):39-44. PubMed ID: 6393143 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2. Giles H; Bolofo ML; Lydford SJ; Martin GR Br J Pharmacol; 1991 Oct; 104(2):541-9. PubMed ID: 1665742 [TBL] [Abstract][Full Text] [Related]